Andrei, C.; Mihai, D.P.; Zanfirescu, A.; Nitulescu, G.M.; Negres, S.
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity. Pharmaceutics 2022, 14, 2563.
https://doi.org/10.3390/pharmaceutics14122563
AMA Style
Andrei C, Mihai DP, Zanfirescu A, Nitulescu GM, Negres S.
In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity. Pharmaceutics. 2022; 14(12):2563.
https://doi.org/10.3390/pharmaceutics14122563
Chicago/Turabian Style
Andrei, Corina, Dragos Paul Mihai, Anca Zanfirescu, George Mihai Nitulescu, and Simona Negres.
2022. "In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity" Pharmaceutics 14, no. 12: 2563.
https://doi.org/10.3390/pharmaceutics14122563
APA Style
Andrei, C., Mihai, D. P., Zanfirescu, A., Nitulescu, G. M., & Negres, S.
(2022). In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity. Pharmaceutics, 14(12), 2563.
https://doi.org/10.3390/pharmaceutics14122563